Human Centric Lighting to Improve Patient Sleep Parameters
1 other identifier
interventional
13
1 country
1
Brief Summary
Human centric lighting (HCL) is a technology that supports the body's circadian rhythm, as it can stimulate the sleep triggering hormone, melatonin, to improve sleep hygiene over standard lighting (SL), and promote recuperative sleep for a timely return-to-duty. In intensive care units, exposure to HCL has improved sleep measures. However, the effect in the medical surgical (MS) environment is unknown. The purpose of this study is to assess the feasibility of study procedures in MS setting and conduct a preliminary evaluation of the effect of light on inpatient sleep. Recruitment started November 2020 through April 2021. Data analysis is pending.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2020
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
May 15, 2021
CompletedFirst Submitted
Initial submission to the registry
June 25, 2021
CompletedFirst Posted
Study publicly available on registry
September 10, 2021
CompletedSeptember 10, 2021
September 1, 2021
6 months
June 25, 2021
September 3, 2021
Conditions
Outcome Measures
Primary Outcomes (5)
Total Sleep Time
Assess the feasibility of measuring total sleep time in MS setting, using an actigraphy device.
During participant's inpatient stay, not to exceed 5 days.
Sleep Efficiency
Assess the feasibility of measuring sleep efficiency in MS setting, using an actigraphy device.
During participant's inpatient stay, not to exceed 5 days.
Sleep Patterns
Assess the feasibility of assessing sleep patterns in MS setting, using a Consensus Sleep Diary (CSD).
During participant's inpatient stay, not to exceed 5 days.
Dim Light Melatonin Onset - collection
Assess the feasibility of collecting samples to assess dim light melatonin onset in MS setting, using passive drool saliva sampling.
During participant's inpatient stay, not to exceed 5 days.
Patient experience
Describe the patient's experience of participating in the study, in a MS setting, using a semi-structured interview (SSI).
One time - approximately a 5 to 15 minute interview
Secondary Outcomes (1)
Dim Light Melatonin Onset - analysis
Collected during participant's inpatient stay, not to exceed 5 days.
Study Arms (2)
Human Central Lighting (HCL) Room
EXPERIMENTALThis inpatient room was outfitted with lights that mimic the day/night cycle, thereby supporting circadian rhythm. Day time lights were automatically on during 0600 to 1900 and in use any time the patients would normally utilize their lights, with a goal of three hours of light exposure per day. The lights automatically transitioned to warmer toned evening lighting at 1900.
Standard Hospital Lighting (SL) Room
NO INTERVENTIONThe lighting in this room was standard florescent hospital lighting. The only changes in the lighting was the on/off settings normally associated with lighting.
Interventions
Bright light is emitted during the day from 06:00, then auto-dimmed light is used at night, beginning 19:00.
Eligibility Criteria
You may qualify if:
- Patient who is an active duty service member, GS Civilian, Dependent or Retiree affiliated with the Army, Air Force or Navy.
- Patient who is informed by provider or anticipates being admitted for at least two nights.
- Patient who can read and speak English fluently (since surveys are not translated in any other language).
You may not qualify if:
- Patient with visual impairment which cannot be corrected with glasses or contact lenses such as complete blindness, (defined as inability to see light), or partial blindness (defined as very limited vision) such as patients with history of cataracts.
- Patient taking an oral medication for sleep.
- Patient receiving radioactive ionization treatment.
- Patient who requires isolation or palliative care.
- Patient recovering from head/neck or oral maxillofacial surgery that would impede saliva sample collection (i.e. jaw wiring, extensive gauze packing in oral cavity)
- Patient who reports status as a Department of Defense Contractor at screening.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Landstuhl Regional Medical Center
Landstuhl, Germany
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Pauline A Swiger, PhD
US Army Landstuhl Regional Medical Ceneter
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- FED
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- On-Site Principal Investigator
Study Record Dates
First Submitted
June 25, 2021
First Posted
September 10, 2021
Study Start
November 1, 2020
Primary Completion
April 30, 2021
Study Completion
May 15, 2021
Last Updated
September 10, 2021
Record last verified: 2021-09
Data Sharing
- IPD Sharing
- Will not share